Compare CNA & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNA | SNN |
|---|---|---|
| Founded | 1853 | 1856 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 14.3B |
| IPO Year | N/A | N/A |
| Metric | CNA | SNN |
|---|---|---|
| Price | $48.88 | $36.21 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | 384.4K | ★ 896.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.93% | 2.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.71 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ $10.55 | $64.43 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.29 | $23.91 |
| 52 Week High | $51.34 | $38.79 |
| Indicator | CNA | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 65.02 |
| Support Level | $48.21 | $35.48 |
| Resistance Level | $49.87 | $36.25 |
| Average True Range (ATR) | 1.03 | 0.65 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 46.33 | 97.35 |
CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.